Global Clascoterone Market

Clascoterone Comprehensive Study by Type (97% purity, 98% purity, 99% purity), Application (Acne, Hair loss), Distribution Channel (Direct, Indirect) Players and Region - Global Market Outlook to 2027

Clascoterone Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Clascoterone, also known as Winlevi, is an antiandrogen medication used topically to treat acne. It is also being developed in a higher concentration under the brand name Breezula for the treatment of androgen-dependent scalp hair loss. The cream-like medication is applied to the skin, such as the face and scalp. Clascoterone is an androgen receptor (AR) antagonist or antiandrogen. Androgens such as testosterone and dihydrotestosterone have a biological target in the AR. It has very little systemic absorption when applied to the skin.This growth is primarily driven by Growing Hair Loss and Acne Problems has Been Driving the Market Growth..

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitN
Value UnitUSD (Million)
Key Companies in StudySun Pharmaceutical Industries Ltd. (India), Symbiotec (India), Aspen Pharmacare (South Africa), Teva Pharmaceuticals (Israel), Curia (United States), Bulat Pharmaceutical (India), Farmabios (Italy), SEQENS SAS (France), Shandong Sihuan Pharmaceutical (China) and Cosmo Pharmaceuticals (Ireland)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Sun Pharmaceutical Industries Ltd. (India), Symbiotec (India), Aspen Pharmacare (South Africa), Teva Pharmaceuticals (Israel), Curia (United States), Bulat Pharmaceutical (India), Farmabios (Italy), SEQENS SAS (France), Shandong Sihuan Pharmaceutical (China) and Cosmo Pharmaceuticals (Ireland), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
Sun Pharmaceutical Industries Limited received the certified copy of the order passed by the National Company Law Tribunal, Ahmedabad Bench in August 2021, approving the Scheme of Amalgamation and Merger of Sun Pharma Global FZE (Transferor Company), an indirect wholly-owned subsidiary of the Company with the company (Transferee Company), and their respective members and creditors (Scheme), for the merger of the Transferor Company with the Transferee Company.
The first-in-class topical treatment for acne vulgaris, clascoterone (Winlevi, Sun Pharmaceuticals) cream 1%, has officially launched in the United States. The topical androgen receptor inhibitor was first approved by the FDA in August 2020 to treat patients 12 years and older who have acne vulgaris. The cream launched in November 2021 in the United States.To entice more end users, market players are focusing on providing clascoterone of higher quality while adhering to all regulatory standards. In the global clascoterone market, there are numerous large providers. They are also concentrating on the implementation of numerous advanced technologies in drug manufacturing and R&D. Furthermore, the numerous industry profits have led to the entry of new players, raising the level of rivalry in an already competitive market. The clascoterone market is currently expanding due to the rapid advancement of technology in pharmaceuticals. Some of the key players in this market follow strategies, which include new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions.

Regulatory Insights:
PART 320 - BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS Subpart B - Procedures for Determining the Bioavailability or Bioequivalence of Drug Products Sec. 320.21 Requirements for submission of bioavailability and bioequivalence data. (a) Any person submitting a full new drug application to the Food and Drug Administration (FDA) shall include in the application either: (1) Evidence measuring the in vivo bioavailability of the drug product that is the subject of the application; or (2) Information to permit FDA to waive the submission of evidence measuring in vivo bioavailability.

Clascoterone Market Dynamics:
AttributesDetails
Growth Drivers
  • Growing Hair Loss and Acne Problems has Been Driving the Market Growth.
Influencing Trends
  • Rise in Acne and Hair Loss at Young Age.
Restraints
  • Known Side Effects of Drug will be Hindering the Market Growth.
Road Blocks / Challenges
  • Regulations for Approval and Approval Process will be challenging for Market Growth.
Gaps & Opportunities
  • Investments in R&D and Product Development will be Bringing More Opportunities in Market.


AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Clascoterone Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the medium utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Clascoterone Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, SEC filings of Clascoterone players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Clascoterone Study Sheds Light on
— The Clascoterone Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Clascoterone industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Clascoterone industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Know Research Methodology Book Report Now

Report Objectives / Segmentation Covered

By Type
  • 97% purity
  • 98% purity
  • 99% purity
By Application
  • Acne
  • Hair loss
By Distribution Channel
  • Direct
  • Indirect

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Hair Loss and Acne Problems has Been Driving the Market Growth.
    • 3.3. Market Challenges
      • 3.3.1. Regulations for Approval and Approval Process will be challenging for Market Growth.
    • 3.4. Market Trends
      • 3.4.1. Rise in Acne and Hair Loss at Young Age.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clascoterone, by Type, Application, Distribution Channel and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Clascoterone (Value)
      • 5.2.1. Global Clascoterone by: Type (Value)
        • 5.2.1.1. 97% purity
        • 5.2.1.2. 98% purity
        • 5.2.1.3. 99% purity
      • 5.2.2. Global Clascoterone by: Application (Value)
        • 5.2.2.1. Acne
        • 5.2.2.2. Hair loss
      • 5.2.3. Global Clascoterone by: Distribution Channel (Value)
        • 5.2.3.1. Direct
        • 5.2.3.2. Indirect
      • 5.2.4. Global Clascoterone Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Clascoterone (Price)
      • 5.3.1. Global Clascoterone by: Type (Price)
  • 6. Clascoterone: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sun Pharmaceutical Industries Ltd. (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Symbiotec (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aspen Pharmacare (South Africa)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teva Pharmaceuticals (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Curia (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bulat Pharmaceutical (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Farmabios (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. SEQENS SAS (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Shandong Sihuan Pharmaceutical (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cosmo Pharmaceuticals (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clascoterone Sale, by Type, Application, Distribution Channel and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Clascoterone (Value)
      • 7.2.1. Global Clascoterone by: Type (Value)
        • 7.2.1.1. 97% purity
        • 7.2.1.2. 98% purity
        • 7.2.1.3. 99% purity
      • 7.2.2. Global Clascoterone by: Application (Value)
        • 7.2.2.1. Acne
        • 7.2.2.2. Hair loss
      • 7.2.3. Global Clascoterone by: Distribution Channel (Value)
        • 7.2.3.1. Direct
        • 7.2.3.2. Indirect
      • 7.2.4. Global Clascoterone Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Clascoterone (Price)
      • 7.3.1. Global Clascoterone by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clascoterone: by Type(USD Million)
  • Table 2. Clascoterone 97% purity , by Region USD Million (2016-2021)
  • Table 3. Clascoterone 98% purity , by Region USD Million (2016-2021)
  • Table 4. Clascoterone 99% purity , by Region USD Million (2016-2021)
  • Table 5. Clascoterone: by Application(USD Million)
  • Table 6. Clascoterone Acne , by Region USD Million (2016-2021)
  • Table 7. Clascoterone Hair loss , by Region USD Million (2016-2021)
  • Table 8. Clascoterone: by Distribution Channel(USD Million)
  • Table 9. Clascoterone Direct , by Region USD Million (2016-2021)
  • Table 10. Clascoterone Indirect , by Region USD Million (2016-2021)
  • Table 11. South America Clascoterone, by Country USD Million (2016-2021)
  • Table 12. South America Clascoterone, by Type USD Million (2016-2021)
  • Table 13. South America Clascoterone, by Application USD Million (2016-2021)
  • Table 14. South America Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 15. Brazil Clascoterone, by Type USD Million (2016-2021)
  • Table 16. Brazil Clascoterone, by Application USD Million (2016-2021)
  • Table 17. Brazil Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 18. Argentina Clascoterone, by Type USD Million (2016-2021)
  • Table 19. Argentina Clascoterone, by Application USD Million (2016-2021)
  • Table 20. Argentina Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 21. Rest of South America Clascoterone, by Type USD Million (2016-2021)
  • Table 22. Rest of South America Clascoterone, by Application USD Million (2016-2021)
  • Table 23. Rest of South America Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 24. Asia Pacific Clascoterone, by Country USD Million (2016-2021)
  • Table 25. Asia Pacific Clascoterone, by Type USD Million (2016-2021)
  • Table 26. Asia Pacific Clascoterone, by Application USD Million (2016-2021)
  • Table 27. Asia Pacific Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 28. China Clascoterone, by Type USD Million (2016-2021)
  • Table 29. China Clascoterone, by Application USD Million (2016-2021)
  • Table 30. China Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 31. Japan Clascoterone, by Type USD Million (2016-2021)
  • Table 32. Japan Clascoterone, by Application USD Million (2016-2021)
  • Table 33. Japan Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 34. India Clascoterone, by Type USD Million (2016-2021)
  • Table 35. India Clascoterone, by Application USD Million (2016-2021)
  • Table 36. India Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 37. South Korea Clascoterone, by Type USD Million (2016-2021)
  • Table 38. South Korea Clascoterone, by Application USD Million (2016-2021)
  • Table 39. South Korea Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 40. Taiwan Clascoterone, by Type USD Million (2016-2021)
  • Table 41. Taiwan Clascoterone, by Application USD Million (2016-2021)
  • Table 42. Taiwan Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 43. Australia Clascoterone, by Type USD Million (2016-2021)
  • Table 44. Australia Clascoterone, by Application USD Million (2016-2021)
  • Table 45. Australia Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 46. Rest of Asia-Pacific Clascoterone, by Type USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Clascoterone, by Application USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 49. Europe Clascoterone, by Country USD Million (2016-2021)
  • Table 50. Europe Clascoterone, by Type USD Million (2016-2021)
  • Table 51. Europe Clascoterone, by Application USD Million (2016-2021)
  • Table 52. Europe Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 53. Germany Clascoterone, by Type USD Million (2016-2021)
  • Table 54. Germany Clascoterone, by Application USD Million (2016-2021)
  • Table 55. Germany Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 56. France Clascoterone, by Type USD Million (2016-2021)
  • Table 57. France Clascoterone, by Application USD Million (2016-2021)
  • Table 58. France Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 59. Italy Clascoterone, by Type USD Million (2016-2021)
  • Table 60. Italy Clascoterone, by Application USD Million (2016-2021)
  • Table 61. Italy Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 62. United Kingdom Clascoterone, by Type USD Million (2016-2021)
  • Table 63. United Kingdom Clascoterone, by Application USD Million (2016-2021)
  • Table 64. United Kingdom Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 65. Netherlands Clascoterone, by Type USD Million (2016-2021)
  • Table 66. Netherlands Clascoterone, by Application USD Million (2016-2021)
  • Table 67. Netherlands Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 68. Rest of Europe Clascoterone, by Type USD Million (2016-2021)
  • Table 69. Rest of Europe Clascoterone, by Application USD Million (2016-2021)
  • Table 70. Rest of Europe Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 71. MEA Clascoterone, by Country USD Million (2016-2021)
  • Table 72. MEA Clascoterone, by Type USD Million (2016-2021)
  • Table 73. MEA Clascoterone, by Application USD Million (2016-2021)
  • Table 74. MEA Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 75. Middle East Clascoterone, by Type USD Million (2016-2021)
  • Table 76. Middle East Clascoterone, by Application USD Million (2016-2021)
  • Table 77. Middle East Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 78. Africa Clascoterone, by Type USD Million (2016-2021)
  • Table 79. Africa Clascoterone, by Application USD Million (2016-2021)
  • Table 80. Africa Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 81. North America Clascoterone, by Country USD Million (2016-2021)
  • Table 82. North America Clascoterone, by Type USD Million (2016-2021)
  • Table 83. North America Clascoterone, by Application USD Million (2016-2021)
  • Table 84. North America Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 85. United States Clascoterone, by Type USD Million (2016-2021)
  • Table 86. United States Clascoterone, by Application USD Million (2016-2021)
  • Table 87. United States Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 88. Canada Clascoterone, by Type USD Million (2016-2021)
  • Table 89. Canada Clascoterone, by Application USD Million (2016-2021)
  • Table 90. Canada Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 91. Mexico Clascoterone, by Type USD Million (2016-2021)
  • Table 92. Mexico Clascoterone, by Application USD Million (2016-2021)
  • Table 93. Mexico Clascoterone, by Distribution Channel USD Million (2016-2021)
  • Table 94. Clascoterone: by Type(USD/Units)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Clascoterone: by Type(USD Million)
  • Table 106. Clascoterone 97% purity , by Region USD Million (2022-2027)
  • Table 107. Clascoterone 98% purity , by Region USD Million (2022-2027)
  • Table 108. Clascoterone 99% purity , by Region USD Million (2022-2027)
  • Table 109. Clascoterone: by Application(USD Million)
  • Table 110. Clascoterone Acne , by Region USD Million (2022-2027)
  • Table 111. Clascoterone Hair loss , by Region USD Million (2022-2027)
  • Table 112. Clascoterone: by Distribution Channel(USD Million)
  • Table 113. Clascoterone Direct , by Region USD Million (2022-2027)
  • Table 114. Clascoterone Indirect , by Region USD Million (2022-2027)
  • Table 115. South America Clascoterone, by Country USD Million (2022-2027)
  • Table 116. South America Clascoterone, by Type USD Million (2022-2027)
  • Table 117. South America Clascoterone, by Application USD Million (2022-2027)
  • Table 118. South America Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 119. Brazil Clascoterone, by Type USD Million (2022-2027)
  • Table 120. Brazil Clascoterone, by Application USD Million (2022-2027)
  • Table 121. Brazil Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 122. Argentina Clascoterone, by Type USD Million (2022-2027)
  • Table 123. Argentina Clascoterone, by Application USD Million (2022-2027)
  • Table 124. Argentina Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 125. Rest of South America Clascoterone, by Type USD Million (2022-2027)
  • Table 126. Rest of South America Clascoterone, by Application USD Million (2022-2027)
  • Table 127. Rest of South America Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 128. Asia Pacific Clascoterone, by Country USD Million (2022-2027)
  • Table 129. Asia Pacific Clascoterone, by Type USD Million (2022-2027)
  • Table 130. Asia Pacific Clascoterone, by Application USD Million (2022-2027)
  • Table 131. Asia Pacific Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 132. China Clascoterone, by Type USD Million (2022-2027)
  • Table 133. China Clascoterone, by Application USD Million (2022-2027)
  • Table 134. China Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 135. Japan Clascoterone, by Type USD Million (2022-2027)
  • Table 136. Japan Clascoterone, by Application USD Million (2022-2027)
  • Table 137. Japan Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 138. India Clascoterone, by Type USD Million (2022-2027)
  • Table 139. India Clascoterone, by Application USD Million (2022-2027)
  • Table 140. India Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 141. South Korea Clascoterone, by Type USD Million (2022-2027)
  • Table 142. South Korea Clascoterone, by Application USD Million (2022-2027)
  • Table 143. South Korea Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 144. Taiwan Clascoterone, by Type USD Million (2022-2027)
  • Table 145. Taiwan Clascoterone, by Application USD Million (2022-2027)
  • Table 146. Taiwan Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 147. Australia Clascoterone, by Type USD Million (2022-2027)
  • Table 148. Australia Clascoterone, by Application USD Million (2022-2027)
  • Table 149. Australia Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 150. Rest of Asia-Pacific Clascoterone, by Type USD Million (2022-2027)
  • Table 151. Rest of Asia-Pacific Clascoterone, by Application USD Million (2022-2027)
  • Table 152. Rest of Asia-Pacific Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 153. Europe Clascoterone, by Country USD Million (2022-2027)
  • Table 154. Europe Clascoterone, by Type USD Million (2022-2027)
  • Table 155. Europe Clascoterone, by Application USD Million (2022-2027)
  • Table 156. Europe Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 157. Germany Clascoterone, by Type USD Million (2022-2027)
  • Table 158. Germany Clascoterone, by Application USD Million (2022-2027)
  • Table 159. Germany Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 160. France Clascoterone, by Type USD Million (2022-2027)
  • Table 161. France Clascoterone, by Application USD Million (2022-2027)
  • Table 162. France Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 163. Italy Clascoterone, by Type USD Million (2022-2027)
  • Table 164. Italy Clascoterone, by Application USD Million (2022-2027)
  • Table 165. Italy Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 166. United Kingdom Clascoterone, by Type USD Million (2022-2027)
  • Table 167. United Kingdom Clascoterone, by Application USD Million (2022-2027)
  • Table 168. United Kingdom Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 169. Netherlands Clascoterone, by Type USD Million (2022-2027)
  • Table 170. Netherlands Clascoterone, by Application USD Million (2022-2027)
  • Table 171. Netherlands Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 172. Rest of Europe Clascoterone, by Type USD Million (2022-2027)
  • Table 173. Rest of Europe Clascoterone, by Application USD Million (2022-2027)
  • Table 174. Rest of Europe Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 175. MEA Clascoterone, by Country USD Million (2022-2027)
  • Table 176. MEA Clascoterone, by Type USD Million (2022-2027)
  • Table 177. MEA Clascoterone, by Application USD Million (2022-2027)
  • Table 178. MEA Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 179. Middle East Clascoterone, by Type USD Million (2022-2027)
  • Table 180. Middle East Clascoterone, by Application USD Million (2022-2027)
  • Table 181. Middle East Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 182. Africa Clascoterone, by Type USD Million (2022-2027)
  • Table 183. Africa Clascoterone, by Application USD Million (2022-2027)
  • Table 184. Africa Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 185. North America Clascoterone, by Country USD Million (2022-2027)
  • Table 186. North America Clascoterone, by Type USD Million (2022-2027)
  • Table 187. North America Clascoterone, by Application USD Million (2022-2027)
  • Table 188. North America Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 189. United States Clascoterone, by Type USD Million (2022-2027)
  • Table 190. United States Clascoterone, by Application USD Million (2022-2027)
  • Table 191. United States Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 192. Canada Clascoterone, by Type USD Million (2022-2027)
  • Table 193. Canada Clascoterone, by Application USD Million (2022-2027)
  • Table 194. Canada Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 195. Mexico Clascoterone, by Type USD Million (2022-2027)
  • Table 196. Mexico Clascoterone, by Application USD Million (2022-2027)
  • Table 197. Mexico Clascoterone, by Distribution Channel USD Million (2022-2027)
  • Table 198. Clascoterone: by Type(USD/Units)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clascoterone: by Type USD Million (2016-2021)
  • Figure 5. Global Clascoterone: by Application USD Million (2016-2021)
  • Figure 6. Global Clascoterone: by Distribution Channel USD Million (2016-2021)
  • Figure 7. South America Clascoterone Share (%), by Country
  • Figure 8. Asia Pacific Clascoterone Share (%), by Country
  • Figure 9. Europe Clascoterone Share (%), by Country
  • Figure 10. MEA Clascoterone Share (%), by Country
  • Figure 11. North America Clascoterone Share (%), by Country
  • Figure 12. Global Clascoterone: by Type USD/Units (2016-2021)
  • Figure 13. Global Clascoterone share by Players 2021 (%)
  • Figure 14. Global Clascoterone share by Players (Top 3) 2021(%)
  • Figure 15. Global Clascoterone share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Sun Pharmaceutical Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 18. Sun Pharmaceutical Industries Ltd. (India) Revenue: by Geography 2021
  • Figure 19. Symbiotec (India) Revenue, Net Income and Gross profit
  • Figure 20. Symbiotec (India) Revenue: by Geography 2021
  • Figure 21. Aspen Pharmacare (South Africa) Revenue, Net Income and Gross profit
  • Figure 22. Aspen Pharmacare (South Africa) Revenue: by Geography 2021
  • Figure 23. Teva Pharmaceuticals (Israel) Revenue, Net Income and Gross profit
  • Figure 24. Teva Pharmaceuticals (Israel) Revenue: by Geography 2021
  • Figure 25. Curia (United States) Revenue, Net Income and Gross profit
  • Figure 26. Curia (United States) Revenue: by Geography 2021
  • Figure 27. Bulat Pharmaceutical (India) Revenue, Net Income and Gross profit
  • Figure 28. Bulat Pharmaceutical (India) Revenue: by Geography 2021
  • Figure 29. Farmabios (Italy) Revenue, Net Income and Gross profit
  • Figure 30. Farmabios (Italy) Revenue: by Geography 2021
  • Figure 31. SEQENS SAS (France) Revenue, Net Income and Gross profit
  • Figure 32. SEQENS SAS (France) Revenue: by Geography 2021
  • Figure 33. Shandong Sihuan Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 34. Shandong Sihuan Pharmaceutical (China) Revenue: by Geography 2021
  • Figure 35. Cosmo Pharmaceuticals (Ireland) Revenue, Net Income and Gross profit
  • Figure 36. Cosmo Pharmaceuticals (Ireland) Revenue: by Geography 2021
  • Figure 37. Global Clascoterone: by Type USD Million (2022-2027)
  • Figure 38. Global Clascoterone: by Application USD Million (2022-2027)
  • Figure 39. Global Clascoterone: by Distribution Channel USD Million (2022-2027)
  • Figure 40. South America Clascoterone Share (%), by Country
  • Figure 41. Asia Pacific Clascoterone Share (%), by Country
  • Figure 42. Europe Clascoterone Share (%), by Country
  • Figure 43. MEA Clascoterone Share (%), by Country
  • Figure 44. North America Clascoterone Share (%), by Country
  • Figure 45. Global Clascoterone: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Sun Pharmaceutical Industries Ltd. (India)
  • Symbiotec (India)
  • Aspen Pharmacare (South Africa)
  • Teva Pharmaceuticals (Israel)
  • Curia (United States)
  • Bulat Pharmaceutical (India)
  • Farmabios (Italy)
  • SEQENS SAS (France)
  • Shandong Sihuan Pharmaceutical (China)
  • Cosmo Pharmaceuticals (Ireland)
Select User Access Type

Key Highlights of Report


Aug 2022 240 Pages 83 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Clascoterone Market Quantitative research analysis
Global Clascoterone Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Clascoterone Market are Sun Pharmaceutical Industries Ltd. (India), Symbiotec (India), Aspen Pharmacare (South Africa), Teva Pharmaceuticals (Israel), Curia (United States), Bulat Pharmaceutical (India), Farmabios (Italy), SEQENS SAS (France), Shandong Sihuan Pharmaceutical (China) and Cosmo Pharmaceuticals (Ireland) etc.
Acne segment in Global market to hold robust market share owing to "Growing Hair Loss and Acne Problems has Been Driving the Market Growth.".

Know More About Global Clascoterone Market Report?

Have a Query? Click Here

Other Related Reports

Gelatin Peptide Plasma Substitute Comprehensive Study by Type (Urea Bridged Gelatin Polypeptide, Succinic Acid Gelatin Polypeptide, Poly Gelatin Peptide), Application (Hospital, Clinic, Other) Player...
$ 3800